Rooibos influences glucocorticoid levels and steroid ratios in vivo and in vitro: A natural approach in the management of stress and metabolic disorders?

Molecular Nutrition and Food Research

Volumn 58, Issue 3, 2014, Pages 537-549

  Schloms, Lindie ^a   Smith, Carine ^a   Storbeck, Karl Heinz ^a   Marnewick, Jeanine L ^b   Swart, Pieter ^a   Swart, Amanda C ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b CAPE PENINSULA UNIVERSITY OF TECHNOLOGY   (South Africa)

Author keywords

Adrenal H295R cells; Cytochrome P450; Functional food; Metabolic syndrome; Rooibos tea polyphenol flavonoids

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CORTICOSTERONE; CORTISONE; GLUCOCORTICOID; HYDROCORTISONE; PLANT EXTRACT; RUTOSIDE; STEROID;

ADRENAL GLAND; ANIMAL; ASPALATHUS; BLOOD; CARDIOVASCULAR DISEASES; CHEMISTRY; CHO CELL LINE; CLINICAL TRIAL; CRICETULUS; CYTOLOGY; DIET SUPPLEMENTATION; DIET THERAPY; DRUG EFFECTS; FEMALE; GENETICS; MALE; METABOLISM; OXIDATIVE STRESS; WISTAR RAT;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; ADRENAL GLANDS; ANIMALS; ASPALATHUS; CARDIOVASCULAR DISEASES; CHO CELLS; CORTICOSTERONE; CORTISONE; CRICETULUS; DIETARY SUPPLEMENTS; FEMALE; GLUCOCORTICOIDS; HYDROCORTISONE; MALE; OXIDATIVE STRESS; PLANT EXTRACTS; RATS, WISTAR; RUTIN; STEROIDS;

EID: 84897584353     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201300463     Document Type: Article

References (34)

1. Perishable Products Export Control Board (PPECB), 2012. Top 10 destination markets for South African Rooibos exports, 2011.
2. WESGRO, Sector Overview. (Western Cape Investment and Trade Promotion Agency, Cape Town, South Africa, Website: www.wesgro.org.za) Rooibos Sector Fact Sheet: Tea Market and Trade, 2012.
3. Wilson, N. L. W., Cape natural tea products and the U.S. market: Rooibos rebels ready to raid. Rev Agri. Econ. 2005, 27, 139-148.
4. Roberts, W. A., New Product Trends. Beverages: Form follows function. 2012, 25-29.
5. De Beer, S. W., Joubert, E., 2002. Preparation of tea-like beverages. SA Patent No. 2002/2802.
6. Joubert, E., Gelderblom, W. C. A., Louw, A., de Beer, D., South African herbal teas: Aspalathus linearis, Cyclopia spp. and Athrixia phylicoides-a review. J. Ethnopharmacol. 2008, 119, 376-412.
7. Ohno, S., Shinoda, S., Toyoshima, S., Nakazawa, H. et al., Effects of flavonoid phytochemicals on cortisol production and on activities of steroidogenic enzymes in human adrenocortical H295R cells. J. Steroid Biochem. Mol. Biol. 2002, 80, 355-363.
8. Schloms, L., Storbeck, K.-H., Swart, P., Gelderblom, W. C. A. et al., The influence of Aspalathus linearis (Rooibos) and dihydrochalcones on adrenal steroidogenesis: Quantification of steroid intermediates and end products in H295R cells. J. Steroid Biochem. Mol. Biol. 2012, 128, 128-138.
9. Payne, H., Hales, D. B., Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocrinol. Rev. 2004, 25, 947-970.
10. New, M. I., Wilson, R. C., Steroid disorders in children: congenital adrenal hyperplasia and apparent mineralocorticoid excess. Proc. Natl. Acad. Sci. USA 1999, 96, 12790-12797.
11. Schweizer, R. A. S., Atanasov, A. G., Frey, B. M., Odermatt, A., A rapid screening assay for inhibitors of 11β-hydroxysteroid dehydrogenases (11β-HSD): flavanones selectively inhibits 11β-HSD1 reductase activity. Mol. Cell. Endocrinol. 2003, 212, 41-49.
12. Beelders, T., Sigge, G. O., Joubert, E., de Beer, D. et al., Kinetic optimization of the reversed phase liquid chromatographic separation of rooibos tea (Aspalathus linearis) phenolics on conventional high performance liquid chromatographic instrumentation. J. Chromatogr. A. 2012, 1219, 128-139.
13. Marnewick, J. L., Rautenbach, F., Venter, I., Neethling, H. et al., Effects of rooibos (Aspalathus linearis) on oxidative stress and biochemical parameters in adults at risk for cardiovascular disease. J. Ethnopharm. 2011, 133, 46-52.
14. Reagan-Shaw, S., Nihal, M., Ahmad, N., Dose translation from animal to human studies revisited. FASEB J. 2007, 22, 659-661.
15. Storbeck, K.-H., Kolar, N. W., Stander, M., Swart, A. C. et al., The development of an ultra performance liquid chromatography coupled atmospheric pressure chemical ionization mass spectrometry assay for seven adrenal steroids. Anal. Biochem. 2008, 372, 11-20.
16. Heim, C., Ehlert, U., Hellhammer, D. H., The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology 2000, 25, 1-35.
17. Bujalska, J., Draper, N., Michailidou, Z., Tomlinson, J. W. et al., Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11β-hydroxysteroid dehydrogenase type 1. J. Mol. Endocrinol. 2005, 34, 675-684.
18. Cooper, M. S., Stewart, P. M., 11β-Hydroxysteroid dehydrogenase type 1 and its role in the hypothalamus-pituitary-adrenal axis, metabolic syndrome, and inflammation. J. Clin. Endocrinol. Metab. 2009, 94, 4645-4654.
19. Tomlinson, J. W., Stewart, P. M., 11β-Hydroxysteroid dehydrogenase type 1 as a therapeutic target in the metabolic syndrome. Drug Discov. Today Ther. Strateg. 2005, 2, 93-96.
20. Hodek, P., Trefil, P., Stiborova, M., Mini review: Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450. Chem. Biol. Interact. 2002, 139, 1-21.
21. Stalmach, A., Mullen, W., Pecorari, M., Serafini, M., et al., Bioavailability of C-linked dihydrochalcone and flavanone glucosides in humans following ingestion of unfermented and fermented rooibos teas. J. Agric. Food Chem. 2009, 57, 7104-7111.
22. Breiter, T., Laue, C., Kressel, G., Groll, S. et al., Bioavailability and antioxidant potential of rooibos flavonoids in humans following the consumption of different rooibos formulations. Food Chem. 2011, 128, 338-347.
23. Rainey, W. E., Bird, I. M., Mason, J. I., The NCI-H295 cell line: a pluripotent model for human adrenocortical studies. Mol. Cell. Endocrinol. 1994, 100, 45-50.
24. Rege, J., Nakamura, Y., Satoh, F., Morimoto, R. et al., Liquid chromatography-tandem mass spectrometry analysis of human adrenal vein 19-carbon steroids before and after ACTH stimulation. J. Clin. Endocrinol. Metab. 2013, 98, 1182-1188.
25. Rosmund, R., Wallerius, S., Wanger, P., Martin, L. et al., A 5-year follow-up study of disease incidence in men with an abnormal hormone pattern. J. Intern. Med. 2003, 254, 386-390.
26. Smith, G. D., Ben-Shlomo, Y., Beswick, A., Yarnell, J., cortisol, testosterone, and coronary heart disease prospective evidence from the caerphilly study. Circulation 2005, 112, 332-340.
27. Phillips, A. C., Carroll, D., Gale, C. R., Lord, J. M. et al., Cortisol, DHEAS, their ratio and the metabolic syndrome: evidence from the vietnam experience study. Eur. J. Endocrinol. 2010, 162, 919-923.
28. Bosy, T. Z., Moore, K. A., Poklis, A., The effect of oral dehydroepiandrosterone (DHEA) on the urine testosterone/epitestosterone (T/E) ratio in human male volunteers. J. Anal. Toxicol. 1998, 22, 455-459.
29. Hasegawa, E., Nakagawa, S., Sato, M., Tachikawa, E. et al., Effect of polyphenols on production of steroid hormones from human adrenocortical NCI-H295R cells. Biol. Pharm. Bull. 2013, 36, 228-237.
30. Kim, D.-H., Jung, E.-A., Sohng, I-S., Han, J-A. et al., Intestinal bacterial metabolism of flavonoids and its relation to some biological activities. Arch. Pharm. Res. 1998, 21, 17-23.
31. Crozier, A., Del Rio, D., Clifford, M. N., Bioavailability of dietary flavonoids and phenolic compounds. Mol. Aspects Med. 2010, 31, 446-467.
32. Ohno, S., Matsumoto, N., Watanabe, M., Nakajin, S., Flavonoid inhibition of overexpressed human 3β-hydroxysteroid dehydrogenase type II. J. Steroid Biochem. Mol. Biol. 2004, 88, 175-182.
33. Sanderson, J. T., Hordijk, J., Denison, M. S., Springsteel, M. F. et al., Induction and inhibition of aromatase (CYP19) activity by natural and synthetic flavonoid compounds in H295R human adrenocortical carcinoma cells. Toxicol. Sci. 2004, 82, 70-79.
34. Mennen, L. I., Walker, R., Bennetau-Pelissero, C., Scalbert, A., Risks and safety of polyphenol consumption. Am. J. Clin. Nutr. 2005, 81, 326S-329S.